Cargando…

Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review

Caffeine is the most used central nervous system stimulant drug to date. Many studies have shown the association of caffeine with bone remodeling, urinary calcium excretion, kidney stones, acid peptic disease, and the development of cancer. However, there has been very little research exploring the...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Mithun K, Murthy, Pooja M, Elsayed, Sarah M, Hussain, Mir Mehdi, Robert, Chris A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510512/
https://www.ncbi.nlm.nih.gov/pubmed/32983662
http://dx.doi.org/10.7759/cureus.9958
_version_ 1783585802823925760
author Reddy, Mithun K
Murthy, Pooja M
Elsayed, Sarah M
Hussain, Mir Mehdi
Robert, Chris A
author_facet Reddy, Mithun K
Murthy, Pooja M
Elsayed, Sarah M
Hussain, Mir Mehdi
Robert, Chris A
author_sort Reddy, Mithun K
collection PubMed
description Caffeine is the most used central nervous system stimulant drug to date. Many studies have shown the association of caffeine with bone remodeling, urinary calcium excretion, kidney stones, acid peptic disease, and the development of cancer. However, there has been very little research exploring the association between caffeine use and parathyroid gland disorders. We shed light on the possible connection between caffeine and parathyroid adenomas, as suggested in the literature.
format Online
Article
Text
id pubmed-7510512
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75105122020-09-24 Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review Reddy, Mithun K Murthy, Pooja M Elsayed, Sarah M Hussain, Mir Mehdi Robert, Chris A Cureus Endocrinology/Diabetes/Metabolism Caffeine is the most used central nervous system stimulant drug to date. Many studies have shown the association of caffeine with bone remodeling, urinary calcium excretion, kidney stones, acid peptic disease, and the development of cancer. However, there has been very little research exploring the association between caffeine use and parathyroid gland disorders. We shed light on the possible connection between caffeine and parathyroid adenomas, as suggested in the literature. Cureus 2020-08-23 /pmc/articles/PMC7510512/ /pubmed/32983662 http://dx.doi.org/10.7759/cureus.9958 Text en Copyright © 2020, Reddy et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Reddy, Mithun K
Murthy, Pooja M
Elsayed, Sarah M
Hussain, Mir Mehdi
Robert, Chris A
Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
title Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
title_full Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
title_fullStr Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
title_full_unstemmed Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
title_short Caffeine as a Neoadjuvant Therapy in Parathyroid Adenomas: A Narrative Review
title_sort caffeine as a neoadjuvant therapy in parathyroid adenomas: a narrative review
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510512/
https://www.ncbi.nlm.nih.gov/pubmed/32983662
http://dx.doi.org/10.7759/cureus.9958
work_keys_str_mv AT reddymithunk caffeineasaneoadjuvanttherapyinparathyroidadenomasanarrativereview
AT murthypoojam caffeineasaneoadjuvanttherapyinparathyroidadenomasanarrativereview
AT elsayedsarahm caffeineasaneoadjuvanttherapyinparathyroidadenomasanarrativereview
AT hussainmirmehdi caffeineasaneoadjuvanttherapyinparathyroidadenomasanarrativereview
AT robertchrisa caffeineasaneoadjuvanttherapyinparathyroidadenomasanarrativereview